⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLRB News
Cellectar Biosciences INC NEW
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
globenewswire.com
CLRB
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
globenewswire.com
CLRB
Form 8-K
sec.gov
CLRB
Santander Financial Crime Transformation Leader Joins ThetaRay to Drive Enterprise AI Adoption
businesswire.com
SAN
CLRB
PAYO
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting
globenewswire.com
CLRB
Form 8-K
sec.gov
CLRB
Form 8-K
sec.gov
CLRB
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
CLRB
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
globenewswire.com
CLRB
Form 8-K
sec.gov
CLRB